Revisiting nature: a review of iridoids as a potential antileishmanial class.

Antileishmanial Iridoids Leishmaniasis Natural products Neglected tropical diseases

Journal

Phytochemistry reviews : proceedings of the Phytochemical Society of Europe
ISSN: 1568-7767
Titre abrégé: Phytochem Rev
Pays: Netherlands
ID NLM: 101198162

Informations de publication

Date de publication:
2022
Historique:
received: 09 09 2020
accepted: 02 03 2021
pubmed: 23 3 2021
medline: 23 3 2021
entrez: 22 3 2021
Statut: ppublish

Résumé

Leishmaniasis still stands as one of the most prevalent neglected tropical diseases in the least developed and emerging countries. The recommended therapeutic arsenal to treat leishmaniasis is characterized by several shortcomings, and resistance has already been reported. Hence, this dramatic background highlights the pressing need to develop novel, affordable, and safe antileishmanial drugs. Multiple classes of natural compounds have been reported to possess antileishmanial activity. Among these classes, iridoids stand out as a special type of monoterpenoids with diverse biological properties-including their antileishmanial potential. This review aims to discuss the available literature between 1991 and 2020 related to the antileishmanial activity of the iridoid class. Throughout the past decades, various investigations attributed antileishmanial action to assorted iridoid types, including inhibitory potential towards validated drug targets and immunomodulatory activity. The latter deserves special attention due to the ability of some iridoids to improve the host's immune response against parasites. It opens the possibility of iridoids become adjuncts in leishmaniasis treatments by improving the efficacy of currently employed drugs. Furthermore, the present study intends to provide a convenient visual representation of which iridoids and

Identifiants

pubmed: 33746658
doi: 10.1007/s11101-021-09750-8
pii: 9750
pmc: PMC7960493
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

101-126

Informations de copyright

© The Author(s), under exclusive licence to Springer Nature B.V. 2021.

Déclaration de conflit d'intérêts

Conflicts of interestThe authors have no conflicts of interest to declare.

Références

F1000Res. 2017 May 26;6:750
pubmed: 28649370
Acta Trop. 2011 Aug;119(2-3):188-93
pubmed: 21679679
Mini Rev Med Chem. 2008 Apr;8(4):399-420
pubmed: 18473930
Molecules. 2020 Jan 10;25(2):
pubmed: 31936853
Phytother Res. 2020 May;34(5):1071-1082
pubmed: 31880854
Int J Clin Pharmacol Ther. 2014 Oct;52(10):880-8
pubmed: 25109414
Int Immunol. 2018 Mar 10;30(3):103-111
pubmed: 29294040
Phytother Res. 2011 Jan;25(1):142-6
pubmed: 20623589
Fitoterapia. 2012 Apr;83(3):500-7
pubmed: 22245081
Phytother Res. 2016 Dec;30(12):1905-1925
pubmed: 27704633
Fortschr Chem Org Naturst. 2000;79:1-114
pubmed: 10838782
Front Cell Infect Microbiol. 2012 Sep 19;2:121
pubmed: 23050244
Clin Med (Lond). 2019 Mar;19(2):157-160
pubmed: 30872302
Pharm Biol. 2017 Dec;55(1):2211-2233
pubmed: 29125010
BMC Public Health. 2018 Mar 15;18(1):358
pubmed: 29544463
Eur J Med Chem. 2017 Jul 28;135:241-259
pubmed: 28456033
Molecules. 2015 Apr 01;20(4):5740-53
pubmed: 25834987
Front Immunol. 2016 May 31;7:212
pubmed: 27303406
Ther Adv Infect Dis. 2016 Jun;3(3-4):98-109
pubmed: 27536354
J Nat Prod. 1991 Jul-Aug;54(4):1102-4
pubmed: 1791475
Bioorg Med Chem Lett. 2015 Aug 1;25(15):3030-3
pubmed: 26048790
Curr Drug Discov Technol. 2019;16(2):173-183
pubmed: 28969568
Mem Inst Oswaldo Cruz. 2013 Jun;108(4):501-7
pubmed: 23827996
Parasit Vectors. 2016 Aug 09;9(1):441
pubmed: 27501956
Parasit Vectors. 2012 Dec 03;5:276
pubmed: 23206339
Fundam Clin Pharmacol. 2008 Dec;22(6):623-32
pubmed: 19049667
Indian J Med Res. 2011 Nov;134(5):709-16
pubmed: 22199112
Curr Pharm Biotechnol. 2009 Sep;10(6):641-9
pubmed: 19619118
Comb Chem High Throughput Screen. 2016;19(7):537-53
pubmed: 27682867
J Antimicrob Chemother. 1999 Dec;44(6):791-4
pubmed: 10590280
Eur J Med Chem. 2012 Aug;54:49-58
pubmed: 22608855
J Antimicrob Chemother. 2012 Nov;67(11):2576-97
pubmed: 22833634
Fitoterapia. 2020 Jan;140:104443
pubmed: 31790767
J Nat Prod. 1996 Jan;59(1):27-9
pubmed: 8984149
Eur J Med Chem. 2020 Oct 1;203:112514
pubmed: 32668302
Pharm Biol. 2016 Sep;54(9):1808-14
pubmed: 26734766
Phytother Res. 2005 Feb;19(2):162-6
pubmed: 15852483
Planta Med. 1992 Dec;58(6):528-32
pubmed: 1484891
Phytother Res. 2019 Oct;33(10):2473-2517
pubmed: 31441148
Exp Parasitol. 2011 Feb;127(2):376-81
pubmed: 20846525
Evid Based Complement Alternat Med. 2013;2013:265025
pubmed: 23840252
Cell Immunol. 2016 Nov;309:1-6
pubmed: 27531526
Parasit Vectors. 2016 May 04;9:264
pubmed: 27146515
Life Sci. 1998;63(20):1823-34
pubmed: 9820126
Antimicrob Agents Chemother. 2016 May 23;60(6):3283-90
pubmed: 26953191
Acta Trop. 2005 Apr;94(1):41-7
pubmed: 15895483
J Liposome Res. 2017 Sep;27(3):234-248
pubmed: 28874072
Int Health. 2019 Sep 2;11(5):338-340
pubmed: 31529110
PLoS Negl Trop Dis. 2019 Feb 25;13(2):e0007092
pubmed: 30802261
J Ethnopharmacol. 2007 Jun 13;112(2):410-4
pubmed: 17459622
Phytomedicine. 2005 Jun;12(6-7):514-35
pubmed: 16008131
Phytother Res. 2016 Oct;30(10):1624-1633
pubmed: 27282639
Front Cell Infect Microbiol. 2019 Sep 19;9:330
pubmed: 31608245
Chem Rev. 2014 Oct 22;114(20):10369-428
pubmed: 25253511
Parasitol Res. 2011 Apr;108(4):793-800
pubmed: 21212980
Carcinogenesis. 2012 Dec;33(12):2424-31
pubmed: 22948180
Pharmacogn Rev. 2013 Jul;7(14):188-98
pubmed: 24347927
Expert Opin Pharmacother. 2019 Jul;20(10):1251-1265
pubmed: 31063412
Trop Med Health. 2016 Aug 05;44:25
pubmed: 27536194
Parasitol Res. 2011 Apr;108(4):861-71
pubmed: 21085992
Nat Rev Microbiol. 2011 Jul 11;9(8):604-15
pubmed: 21747391
Mini Rev Med Chem. 2018;18(1):26-41
pubmed: 28443518
Bioorg Med Chem Lett. 2010 Mar 1;20(5):1520-3
pubmed: 20149652
Phytochemistry. 2005 Feb;66(3):355-62
pubmed: 15680992
PLoS Negl Trop Dis. 2020 May 4;14(5):e0008254
pubmed: 32365060
Biochem Biophys Res Commun. 2005 Sep 2;334(3):769-78
pubmed: 16024000
Biomolecules. 2019 Dec 24;10(1):
pubmed: 31878316
Planta Med. 2004 Aug;70(8):711-7
pubmed: 15326547
Expert Rev Anti Infect Ther. 2019 Jan;17(1):57-69
pubmed: 30513027
Parasitology. 2018 Feb;145(2):219-236
pubmed: 28805165
J Ethnopharmacol. 2011 Apr 12;134(3):996-8
pubmed: 21291983
Phytomedicine. 2008 Mar;15(3):209-15
pubmed: 17761408
J Ethnopharmacol. 2013 Apr 19;146(3):645-58
pubmed: 23376280
Future Microbiol. 2015;10(1):111-29
pubmed: 25598341
Int J Parasitol Parasites Wildl. 2014 Aug 29;3(3):251-62
pubmed: 25426421
Phytomedicine. 2013 Feb 15;20(3-4):275-81
pubmed: 23273752
Infect Dis Poverty. 2020 Jul 10;9(1):86
pubmed: 32646512

Auteurs

Guilherme Arraché Gonçalves (G)

Laboratório de Síntese Orgânica Medicinal (LaSOM), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-000 Brazil.

Vera Lucia Eifler-Lima (VL)

Laboratório de Síntese Orgânica Medicinal (LaSOM), Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-000 Brazil.

Gilsane Lino von Poser (GL)

Laboratório de Farmacognosia, Programa de Pós-Graduação em Ciências Farmacêuticas, Faculdade de Farmácia, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS 90610-000 Brazil.

Classifications MeSH